Symbols

What is the average price target for United healthcare?

8/4/2025 10:50am

``` The deep research logic is organized as follows: Okay, let's tackle the user's question about the average price target for UnitedHealth Group (UNH). First, I need to check the provided references to find the relevant data. Looking at the references, Number 1 has a query specifically about the average price target for UNH as of 2025-05-02 to 2025-08-01. The result shows an average price target of $345.65. That's the primary data point here. Next, I should consider any other mentions of price targets in the references. Number 7 mentions Oppenheimer reducing their price target to $325 from $400, but that's a specific analyst's target, not the average. Number 9 from J.P. Morgan assigns a $418 price target, which is another individual analyst's view. However, the user is asking for the average, so the main data is from reference 1. I also need to check if there are any other relevant data points. Reference 10 mentions the number of analysts contributing to the average price target, which is 17. That adds context about the breadth of the average. The user's profile shows they're interested in high dividend yields and moderate payout ratios, but the question is purely about the average price target. So, I should focus on the data from reference 1 and 10. I should structure the answer by first stating the average price target, then provide context about the number of analysts and any recent changes or analyst opinions. Also, include the visualization as per the requirements. Make sure to cite the references correctly using and . The visualization should be inserted right after the paragraph mentioning the average price target. Double-check that all information is accurate and only from the provided references. No need to include other data like the stock's recent performance unless it's directly related to the price target. Finally, ensure the answer is clear, concise, and formatted with markdown tables and the required structure. Also, add emojis to make it engaging as per the guidelines. ``` ### 🎯 **Conclusion** The **average price target** for UnitedHealth Group (UNH) as of **2025-08-01** is **$345.65**, reflecting a **53.8% upside** from its last closing price of **$237.77** . This consensus estimate is derived from **17 analysts** covering the stock, with recent revisions reflecting mixed sentiment due to operational challenges and strategic adjustments . --- ### 📊 **Analysis** #### 1. **Price Target Breakdown** | Metric | Value | Implication | |----------------------------|----------------|------------------------------------------------------------------------------| | Last Price (2025-08-01) | $237.77 | Recent decline (~56% YTD) due to rising costs, DOJ probe, and leadership changes . | | Average Price Target | $345.65 | 53.8% upside potential; aligns with long-term growth plans (2026+ EPS recovery) . | | Analysts Contributing | 17 | Moderate analyst coverage, with mixed outlooks (e.g., JPMorgan: $418 PT vs. Oppenheimer: $325 PT) . | #### 2. **Key Drivers of Price Target** - **Optimism**: Analysts like JPMorgan ($418 PT) highlight UnitedHealth’s **market dominance** and **AI-driven cost savings** (~$1B in 2026) . - **Cautiousness**: Concerns over **rising medical costs** (MLR hit 89.4%) and **DOJ investigations** have led to downward revisions (e.g., Oppenheimer cut PT to $325) . #### 3. **Why This Matters** - **Bullish Case**: Long-term growth prospects (2026+ EPS acceleration) and dividend stability (3.54% yield, 15-year streak) align with your interest in **high dividend yields** and **low-risk investments** . - **Bearish Case**: Short-term risks (56% YTD decline, leadership shuffle) may test patience, but the stock remains a **“bargain”** at current levels . --- ### 📊 **Takeaway** UnitedHealth Group’s **$345.65 average price target** reflects a **balanced view** of its challenges and opportunities. If you’re looking for a **low-risk, high-dividend play** with **long-term growth potential**, UNH could be a strategic addition to your portfolio. However, stay vigilant to **operational risks** and **analyst revisions** in the near term. 🛡️📈